Con­tract man­u­fac­tur­er Cu­ria names new CEO

3 years ago
People
Manufacturing

Take­da in­vests $760M+ in­to new plas­ma-de­rived ther­a­py man­u­fac­tur­ing site in Japan

3 years ago
Pharma
Manufacturing

Man­u­fac­tur­ing roundup: Cana­da to in­vest $58M+ in­to 'crit­i­cal' med­i­cines man­u­fac­tur­ing; FDA to ac­cept apps for CMC ...

3 years ago
Manufacturing

Mod­er­na part­ners on non-vi­ral gene ther­a­py with Gen­er­a­tion Bio af­ter swing­ing gene edit­ing deals

3 years ago
Deals
R&D

Roy­al­ty Phar­ma hands off $100M up­front for PureTech roy­al­ty on Karuna's schiz­o­phre­nia hope­ful

3 years ago
Deals
R&D

Gilead pass­es on ful­ly ac­quir­ing Pi­o­nyr, as eyes now turn to Tizona, a fel­low sum­mer 2020 buy­out op­tion

3 years ago
Startups
Deals

FDA ap­proves Cidara's Rez­za­yo as an­ti­fun­gal treat­ment for can­didemia and in­va­sive can­didi­a­sis

3 years ago
R&D
FDA+

Up­dat­ed: Ex-Seagen chief Clay Sie­gall emerges as CEO of pri­vate biotech

3 years ago
People

Sanofi, Re­gen­eron boast PhI­II win with Dupix­ent in COPD, clear­ing first bar for ex­pan­sion

3 years ago
R&D
Pharma

Genen­tech to halt com­mer­cial man­u­fac­tur­ing in Cal­i­for­nia HQ, with lay­offs at­tached

3 years ago
People
Manufacturing

FDA ad­vi­sors unan­i­mous­ly rec­om­mend ac­cel­er­at­ed ap­proval for Bio­gen's ALS drug

3 years ago
Pharma
FDA+

In­cyte wins ac­cel­er­at­ed ap­proval for PD-1 in rare skin can­cer

3 years ago
Pharma
FDA+

Fed­er­al judge de­nies Am­gen's mo­tion to dis­miss Re­gen­eron an­titrust case

3 years ago
Pharma
Law

Re­gen­eron scores la­bel ex­pan­sion for cho­les­terol drug Evkeeza

3 years ago
R&D
Pharma

So­cial me­dia pa­tient in­flu­encers ‘danc­ing in the gray’ of phar­ma mar­ket­ing, more clar­i­ty need­ed, re­searcher says

3 years ago
Pharma
Marketing

No­var­tis pulls the plug on UK-based car­dio­vas­cu­lar study

3 years ago
R&D

Drug short­age so­lu­tions brought be­fore Sen­ate Home­land Se­cu­ri­ty com­mit­tee

3 years ago
Pharma
Manufacturing

Mod­er­na CEO de­fends Covid-19 vac­cine price change at Sen­ate com­mit­tee grilling

3 years ago
Coronavirus

FDA re­jects Ab­b­Vie's in­fu­sion ther­a­py for Parkin­son's, re­quests more in­fo on pump de­vice

3 years ago
R&D
Pharma

Bio­haven grabs TYK2/JAK1 drug for $20M to start, $950M on the line — to go af­ter Parkin­son's

3 years ago
Deals

Quince Ther­a­peu­tics faces takeover bid from share­hold­er Echo Lake Cap­i­tal

3 years ago
Financing
R&D

Astel­las flesh­es out more PhI­II da­ta for Claudin 18.2 drug

3 years ago
R&D

FDA+ roundup: Leg­isla­tive asks for 2024 fo­cus on more au­thor­i­ties, gener­ic drug com­pe­ti­tion

3 years ago
FDA+

In in­sulin re­sis­tance pact, Dew­point adds No­vo Nordisk to its phar­ma-rich pipeline

3 years ago
Startups
Deals
First page Previous page 357358359360361362363 Next page Last page
A service from the Financial Times